Carbamazepine in Aggressive Children with Conduct Disorder: A Double-Blind and Placebo-Controlled Study

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 35, Issue 4, 1996, Pages 480-490

  Cueva, Jeanette E ^a,b   Overall, John E ^c   Small, Arthur M ^d   Armenteros, Jorge L ^e   Perry, Richard ^d   Campbell, Magda ^d  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b ST VINCENT S HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^e Columbia University ^*  (United States)

Author keywords

Aggressiveness; Carbamazepine; Conduct disorder; Explosiveness; Overt Aggression Scale

Indexed keywords

CARBAMAZEPINE;

AGGRESSION; ARTICLE; BEHAVIOR DISORDER; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MALE; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL;

AGGRESSION; CARBAMAZEPINE; CHILD; CHILD BEHAVIOR DISORDERS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES;

EID: 0030113110     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-199604000-00014     Document Type: Article

References (75)

1. Aman MG (1978), Drugs, learning, and the psychotherapies. In: Pediatric Psychopharmacology: The Use of Behavior Modifying Drugs in Children, Werry JS, ed. New York: Brunner/Mazel, pp 79-108
2. American Psychiatric Association (1980), Diagnostic and Statistical Manual of Mental Disorders, 3rd edition (DSM-III). Washington, DC: American Psychiatric Association
3. American Psychiatric Association (1987), Diagnostic and Statistical Manual of Mental Disorders, 3rd edition-revised (DSM-III-R). Washington, DC: American Psychiatric Association
4. Andreasen NC, Endicott J, Spitzer RL, Winokur G (1977), The family history method using diagnostic criteria. Arch Gen Psychiatry 34:1229-1235
5. Armenteros JL, Adams PB, Campbell M, Eisenberg ZW (1995), Haloperidol related dyskinesias and pre- and perinatal complications in autistic children. Psychopharmacol Bull 31:363-369
6. Birkmayer W, ed (1976), Epileptic Seizures - Behaviour - Pain (international symposium, St Moritz, January 6-7, 1975). Baltimore: University Park Press
7. Brain PF, Benton D, eds (1981), The Biology of Aggression. Althen Aan Den Rijn, the Netherlands: Sijthoff and Noordhoff
8. Campbell M (1977), Demographic parameters of disturbed children: a template to the CPDI and CSH, its rationale and significance. Psychopharmacol Bull 13:30-33
9. Campbell M, Adams P, Perry R, Spencer EK, Overall JE (1988), Tardive and withdrawal dyskinesia in autistic children: a prospective study. Psychopharmacol Bull 24:251-255
10. Campbell M, Adams P, Small AM et al. (1995), Lithium in hospitalized aggressive children with conduct disorder: a double-blind and placebo-controlled study. J Am Acad Child Adolesc Psychiatry 34:445-453
11. Campbell M, Cohen IL, Small AM (1982), Drugs in aggressive behavior. J Am Acad Child Psychiatry 21:107-117
12. Campbell M, Cueva JE (1995), Psychopharmacology in child and adolescent psychiatry: a review of the past seven years. Part II. J Am Acad Child Adolesc Psychiatry 34:1262-1272
13. Campbell M, Gonzalez NM, Ernst M, Silva RR, Werry JS (1993), Antipsychotics. In: Practitioner's Guide to Psychoactive Drugs for Children and Adolescents, Werry JS, Aman MG, eds. New York: Plenum Press, pp 269-296
14. Campbell M, Gonzalez NM, Silva RR (1992), The pharmacologic treatment of conduct disorders and rage outbursts. Psychiatr Clin North Am 15:69-85
15. Campbell M, Small AM, Green WH et al. (1984), Behavioral efficacy of haloperidol and lithium carbonate: a comparison in hospitalized aggressive children with conduct disorder. Arch Gen Psychiatry 41:650-656
16. DeLong GR, Aldershof AL (1987), Long-term experience with lithium treatment in childhood: correlation with clinical diagnosis. J Am Acad Child Adolesc Psychiatry 26:389-394
17. Dostal T (1972), Antiaggressive effects of lithium salts in mentally retarded adolescents. In: Depressive States in Childhood and Adolescence, Annell AL, ed. Stockholm: Almqvist & Wiksell, pp 491-498
18. Eichelman B (1987), Neurochemical and psychopharmacologic aspects of aggressive behavior. In: Psychopharmacology: The Third Generation of Progress, Meltzer HY, ed. New York: Raven Press, pp 697-704
19. Eichelman B (1992), Aggressive behavior: from laboratory to clinic. Quo vadit? Arch Gen Psychiatry 49:488-492
20. Elliott FA (1984), The episodic dyscontrol syndrome and aggression. Neurol Clin 2:113-125
21. Endicott J, Andreasen N, Spitzer RL (1975), Family History-Research Diagnostic Criteria. New York: Biometrics Research, New York State Psychiatric Institute
22. Evans RW, Clay TH, Gualtieri CT (1987), Carbamazepine in pediatric psychiatry. J Am Acad Child Adolesc Psychiatry 26:2-8
23. Gamstorp I (1976), Carbamazepine in the treatment of epileptic disorders in infancy and childhood. In: Epileptic Seizures-Behaviour-Pain, Birkmayer W, ed. Bern, Switzetland: Hans Huber, pp 98-103
24. Groh C (1976), The psychotropic effect of Tegretol in non-epileptic children, with particular reference to the drug's indications. In: Epileptic Seizures-Behaviour-Pain, Birkmayer W, ed. Bern, Switzerland: Hans Huber, pp 259-263
25. Guy W (1976), ECDEU Assessment Manual for Psychopharmacology (revised) (DHEW Publication ADM 76-338). Rockville, MD: US Department of Health, Education and Welfare
26. Hollingshead AB (1965), Two Factor Index of Social Position. New Haven, CT: privately printed
27. Jacobides G (1978), Alertness and scholastic achievement in young epileptics treated with carbamazepine (Tegretol). In: Psychology and New Diagnostic Approaches, Meinaardi H, Rowan A, eds. Amsterdam: Swets & Zeitlinger, pp 114-119
28. Kafantaris V, Campbell M, Padron-Gayol MV, Small AM, Locascio JJ, Rosenberg CR (1992), Carbamazepine in hospitalized aggressive conduct disorder children: an open pilot study. Psychopharmacol Bull 28: 193-199
29. Kafantaris V, Lee DO, Magee H et al. (in press). Assessment of children with the Overt Aggression Scale. J Neuropsychiatry Clin Neurosci
30. Kagan J (1971), Matching familiar figures. In: Tests and Measurements in Child Development: A Handbook, Johnson OG, Bommarito JW, eds. San Francisco: Jossey-Bass, p 107
31. Kashani JH, Cantwell DP (1983), Characteristics of children admitted to inpatient community mental health center. Arch Gen Psychiatry 40:397-400
32. Kazdin AE (1987), Current treatments. In: Conduct Disorders in Childhood and Adolescence, Kazdin AE, ed. Newbury Park, CA: Sage Publications, pp 73-95
33. Kuhn-Gebhart V (1976), Behavioural disorders in non-epileptic children and their treatment with carbamazepine. In: Epileptic Seizures-Behaviour-Pain, Birkmayer W, ed. Bern, Switzerland: Hans Huber, pp 264-267
34. Laird NM, Ware JH (1982), Random effects models for longitudinal data. Biometrics 38:963-974
35. Leviatov VM, Veselovskaja TD, Marienko GPh, Chtchegoleva AP (1976), Psychoses au Tegretol chez deś epileptiques. Ann Med Psychol 1:473
36. Livingston S, Pauli LL, Berman W (1974), Carbamazepine (Tegretol) in epilepsy. Nine year follow-up with special emphasis on untoward reactions. Dis Nerv Syst 35:103-107
37. MacLeod CM, Dekaban AS, Hunt E (1978), Memory impairment in epileptic patients: selective effects of phenobarbital concentration. Science 202:1102-1104
38. Malone RP, Biesecker KA, Delaney MA, White MA, Luebbert J (1994a), Youth self-report in aggression: baseline placebo responders and nonresponders. In: Scientific Proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Vol X, p 49
39. Malone RP, Biesecker KA, Luebbert JF, White MA, Siam NA (1995), Importance of placebo baseline in clinical drug trials involving aggressive children. Poster presented at New Clinical Drug Evaluation Unit Program, 35th Annual Meeting, May 31-June 3
40. Malone RP, Luebbert J, Pena-Ariet M, Biesecker K, Delaney MA (1994b), The Overt Aggression Scale in a study of lithium in aggressive conduct disorder. Psychopharmacol Bull 30:215-218
41. Moyer KE (1968), Kinds of aggression and their physiological basis. Community Behav Biol A 2:65-87
42. Neppe VM, Tucker GJ, Wilensky AJ (1988), Introduction: fundamentals of carbamazepine use in neuropsychiatry. J Clin Psychiatry 49(4, suppl):4-6
43. O'Donnell DJ (1985), Conduct disorders. In: Diagnosis and Psychopharmacology of Childhood and Adolescent Disorders, Wiener JM, ed. New York: Wiley, pp 249-287
44. Offord DR, Boyle MH, Racine YA (1991), The epidemiology of antisocial behavior in childhood and adolescence. In: The Development and Treatment of Childhood Aggression, Pepler DJ, Rubin KH, eds. Hillsdale, NJ: Erlbaum, pp 31-54
45. Offord DR, Boyle MH, Szatmari P et al. (1987), Ontario Child Health Study: I. Six-month prevalence of disorder and service utilization. Arch Gen Psychiatry 44:832-836
46. Platt JE, Campbell M, Green WH, Grega DM (1984), Cognitive effects of lithium carbonate and haloperidol in treatment-resistant aggressive children. Arch Gen Psychiatry 41:657-662
47. Porteus SD (1965), Porteus Maze Tests: 50 Years' Application. Palo Alto, CA: Pacific Book Publishers
48. Post RM (1987), Mechanisms of action of carbamazepine and related anticonvulsants in affective illness. In: Psychopharmacology: The Third Generation of Progress, Meltzer HY, ed. New York: Raven Press, pp 567-576
49. Pratt JA, Jenner P, Johnson AL, Shorvon SD, Reynolds EH (1984), Anticonvulsant drugs alter plasma tryptophan concentrations in epileptic patients: implications for antiepileptic action and mental function. J Neurol Neurosurg Psychiatry 47:1131-1133
50. Psychopharmacology Bulletin (1985), Special Feature: Rating Scales and Assessment Instruments for Use in Pediatric Psychopharmacology Research. 21(4)
51. Puente RM (1976), The use of carbamazepine in the treatment of behavioural disorders in children. In: Epileptic Seizures-Behaviour-Pain, Birkmayer W, ed. Bern, Switzerland: Hans Huber, pp 243-247
52. Reich W, Shayka JJ, Taibleson C (1991), Diagnostic Interview for Children and Adolescents (DICA-R). St. Louis: Washington University
53. Reis D (1971), Brain monoamines in aggression and sleep. Clin Neurosurg 18:471-502
54. Reis D (1974), Central neurotransmitters in aggression. Res Publ Assoc Res Nerv Ment Dis 52:119-148
55. Remschmidt H (1976), The psychotropic effect of carbamazepine in non-epileptic patients, with particular reference to problems posed by clinical studies in children with behavioural disorders. In: Epileptic Seizures-Behaviour-Pain, Birkmayer W, ed. Bern, Switzerland: Hans Huber, pp 253-258
56. Richardson MA, Haugland G, Craig TJ (1991), Neuroleptic use, parkinsonian symptoms, tardive dyskinesia, and associated factors in child and adolescent psychiatric patients. Am J Psychiatry 148:1322-1328
57. Roy-Byrne PP, Joffe RT, Uhde TW, Post RM (1984), Carbamazepine and thyroid function in affectively ill patients. Arch Gen Psychiatry 41:1150-1153
58. Rutter M, Tizard J, Whitmore K (1970), Education, Health, and Behaviour. New York: Longman
59. Sanchez LE, Armenteros JL, Small AM, Campbell M, Adams PB (1994), Placebo response in aggressive children with conduct disorder. Psychopharmacol Bull 30:209-213
60. Sheard MH, Marini JL, Bridges CI, Wagner E (1976), The effect of lithium on impulsive aggressive behavior in man. Am J Psychiatry 133:1409-1413
61. Sillanpaa M (1981), Carbamazepine. Pharmacology and clinical uses. Acta Neurol Scand 64(suppl 88):1-202
62. Silva RR, Campbell M, Golden RR, Small AM, Pataki CS, Rosenberg CR (1992), Side effects associated with lithium and placebo administration in aggressive children. Psychopharmacol Bull 28:319-326
63. Silver JM, Yudofsky SC (1986), Propranolol in the treatment of chronically hospitalized patients. In: Biological Psychiatry, 1985, Shagass C, Josiassen RC, Bridger WH et al., eds. New York: Elsevier, pp 174-176
64. Silver JM, Yudofsky SC (1987), Documentation of aggression in the assessment of violent patient. Psychiatr Ann 17:375-384
65. Silverstein FS, Parrish MA, Johnston MV (1982), Adverse behavioral reactions in children treated with carbamazepine (Tegretol). J Pediatr 101:785-787
66. Stewart MA, deBlois CS, Meardon J, Cummings C (1980), Aggressive conduct disorder of children: the clinical picture. J Nerv Ment Dis 168:604-610
67. Thorndike R, Hagen EP, Sattler JM (1986), Technical Manual, Stanford Binet Intelligence Scale: Fourth Edition. Chicago: Riverside
68. Trimble MR (1988), Carbamazepine and mood: evidence from patients with seizure disorders. J Clin Psychiatry 49(4, suppl):7-11
69. Vitiello B, Behar D, Hunt J, Stoff D, Ricciuti A (1990), Subtyping aggression in children and adolescents. J Neuropsychiatry Clin Neurosci 2:189-192
70. Wechsler D (1974), Wechsler Intelligence Scale for Children-Revised. New York: Psychological Corporation
71. Werry JS, Aman MG (1975), Methylphenidate and haloperidol in children. Arch Gen Psychiatry 32:790-795
72. Werry JS, Wollersheim JP (1989), Behavior therapy with children and adolescents: a twenty-year overview. J Am Acad Child Adolesc Psychiatry 28:1-18
73. Woodward JA, Overall JE (1977), Testing hypotheses with order category data. J Psychiatr Res 13:169-177
74. Yudofsky SC, Silver JM, Jackson W, Endicott J, Williams D (1986), The Overt Aggression Scale for the objective rating of verbal and physical aggression. Am J Psychiatry 143:35-39
75. Zax M, Sameroff AJ, Babigian HM (1977), Birth outcomes in the offspring of mentally disordered women. Am J Orthopsychiatry 47:218-230